{ "Renal Pelvic Denervation for Uncontrolled High Blood Pressure", "This study is testing a new device called RPD (Renal Pelvic Denervation) from Verve Medical for people with high blood pressure (hypertension) that isn't controlled by two medications. The RPD device uses radiofrequency energy to treat nerves in the kidneys that contribute to high blood pressure. Researchers want to see if this treatment is safe and effective when added to your current blood pressure medications. You could be eligible if you are between 21 and 80 years old, and are currently taking two specific blood pressure medications, including one for the renin-angiotensin system (like an ACE inhibitor or ARB). The main goal is to see how well the treatment works at 2 months after the procedure.", "design": "This interventional study plans to enroll 60 participants. It is a randomized, double-blind, sham-controlled study, meaning some participants will receive the RPD treatment and others a sham (inactive) procedure, without knowing which they received.", "commitments": "You will continue taking your two anti-hypertensive medications without changes until after the 2-month primary endpoint. Safety and effectiveness will be measured through blood pressure checks, kidney function tests, and monitoring for complications at 2, 6, and 12 months after the procedure.", "compensation": "Not stated in the trial record.", "follow_up": "Participants will be followed for safety and effectiveness assessments at 2, 6, and 12 months after the procedure.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.